People · Operator
Named in public records as an officer, director or promoter · active 2010–2010 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Good Start Genetics, Inc. | — | Biotechnology | Series B | $28.2M | $396.9M | 2010 |
Eric D. Boutin at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Eric D. Boutin on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Carl Gordon | 1 | 24 |
| Gary Kurtzman | 1 | 8 |
| Lutz Giebel | 1 | 6 |
| Robert Carpenter | 1 | 5 |
| Marc Beer | 1 | 4 |
| Robert J. Carpenter | 1 | 3 |
| Don Hardison | 1 | 2 |
| CARL J. GORDON | 1 | 2 |
| Marc D. Beer | 1 | 1 |
| Uri J. Laserson | 1 | 1 |
| Don J. Hardison | 1 | 1 |
| Paris J. Wallace | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.